Ocular Therapeutix, Inc. (OCUL)
9.05
-0.11
(-1.20%)
USD |
NASDAQ |
Feb 12, 16:00
9.18
+0.13
(+1.44%)
After-Hours: 20:00
Ocular Therapeutix Total Liabilities (Quarterly) : 156.83M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Boston Scientific Corp. | -- |
| Alnylam Pharmaceuticals, Inc. | 4.618B |
| Vertex Pharmaceuticals, Inc. | 7.544B |
| Bristol Myers Squibb Co. | -- |
| Krystal Biotech, Inc. | 102.22M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 811.14M |
| Shareholders Equity (Quarterly) | 654.31M |
| Debt to Equity Ratio | 0.1176 |
| Current Ratio | 15.39 |
| Net Debt Paydown Yield | -0.01% |